secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phio Pharmaceuticals Corp. (PHIO)
CIK:        0001533040
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0001683168-25-005523
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phio Pharma receives ~$2.5M from warrant exercise, issues new warrants
----------------------------------------------------------------------

- Gross proceeds ~$2.5M from exercise of 928,596 warrants at $2.00 and $2.485 per share.
- Holders issued new unregistered Series J (5-yr term) and Series K (24-mo term) warrants for up to 1,857,192 shares at $2.485/share.
- Holders paid additional $0.125 per new warrant ($232,149 aggregate) as part of inducement.
- H.C. Wainwright receives 7.5% cash fee and placement agent warrants for 69,645 shares.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825005523/0001683168-25-005523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533040/000168316825005523/phio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-005523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer